Fast Five Quiz: BRCA-Associated Metastatic Breast Cancer

Stefania Morganti, MD


April 19, 2023

Approximately 5%-10% of breast cancers are diagnosed in patients carrying germline pathogenic variants in highly penetrant hereditary breast cancer genes, with BRCA1/2 being the most common. BRCA-associated breast cancers tend to present at younger ages than sporadic cancers and are associated with a higher risk for synchronous or metachronous contralateral breast and ovarian cancer. Genetic testing can inform both locoregional and systemic treatment.

How much do you know about BRCA-mutated metastatic breast cancer (MBC)? Test yourself with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.